The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma
Clinical trial NCT04489264 · UNKNOWN
Trial details
- NCT number
- NCT04489264
- Sponsor
- Peking University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-30
- Primary completion
- 2023-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.